nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA12—Topiramate—obesity	0.222	0.553	CbGbCtD
Zoledronate—CA2—Topiramate—obesity	0.179	0.447	CbGbCtD
Zoledronate—FDPS—jaw skeleton—obesity	0.0175	0.174	CbGeAlD
Zoledronate—GGPS1—hindbrain—obesity	0.00927	0.0926	CbGeAlD
Zoledronate—GGPS1—adrenal cortex—obesity	0.00475	0.0475	CbGeAlD
Zoledronate—GGPS1—cardiovascular system—obesity	0.00434	0.0433	CbGeAlD
Zoledronate—GGPS1—pituitary gland—obesity	0.00384	0.0384	CbGeAlD
Zoledronate—GGPS1—adipose tissue—obesity	0.00382	0.0382	CbGeAlD
Zoledronate—GGPS1—adrenal gland—obesity	0.00343	0.0343	CbGeAlD
Zoledronate—GGPS1—endocrine gland—obesity	0.00297	0.0297	CbGeAlD
Zoledronate—FDPS—islet of Langerhans—obesity	0.00276	0.0276	CbGeAlD
Zoledronate—GGPS1—liver—obesity	0.00268	0.0268	CbGeAlD
Zoledronate—CA12—respiratory system—obesity	0.00264	0.0264	CbGeAlD
Zoledronate—FDPS—respiratory system—obesity	0.00261	0.0261	CbGeAlD
Zoledronate—CA2—hindbrain—obesity	0.00222	0.0222	CbGeAlD
Zoledronate—FDPS—adrenal cortex—obesity	0.00219	0.0219	CbGeAlD
Zoledronate—CA2—gall bladder—obesity	0.00219	0.0219	CbGeAlD
Zoledronate—CA14—adrenal gland—obesity	0.00205	0.0205	CbGeAlD
Zoledronate—FDPS—cardiovascular system—obesity	0.002	0.02	CbGeAlD
Zoledronate—FDPS—pituitary gland—obesity	0.00177	0.0177	CbGeAlD
Zoledronate—FDPS—adipose tissue—obesity	0.00176	0.0176	CbGeAlD
Zoledronate—CA12—digestive system—obesity	0.00168	0.0168	CbGeAlD
Zoledronate—FDPS—digestive system—obesity	0.00166	0.0166	CbGeAlD
Zoledronate—CA14—liver—obesity	0.0016	0.016	CbGeAlD
Zoledronate—FDPS—adrenal gland—obesity	0.00158	0.0158	CbGeAlD
Zoledronate—CA2—islet of Langerhans—obesity	0.00143	0.0143	CbGeAlD
Zoledronate—CA12—endocrine gland—obesity	0.00139	0.0139	CbGeAlD
Zoledronate—FDPS—endocrine gland—obesity	0.00137	0.0137	CbGeAlD
Zoledronate—CA2—respiratory system—obesity	0.00135	0.0135	CbGeAlD
Zoledronate—ABCC1—adrenal cortex—obesity	0.00127	0.0127	CbGeAlD
Zoledronate—FDPS—liver—obesity	0.00124	0.0124	CbGeAlD
Zoledronate—CA2—adrenal cortex—obesity	0.00114	0.0114	CbGeAlD
Zoledronate—CA2—cardiovascular system—obesity	0.00104	0.0104	CbGeAlD
Zoledronate—ABCC1—pituitary gland—obesity	0.00103	0.0103	CbGeAlD
Zoledronate—ABCC1—adipose tissue—obesity	0.00102	0.0102	CbGeAlD
Zoledronate—CA2—pituitary gland—obesity	0.000919	0.00918	CbGeAlD
Zoledronate—ABCC1—adrenal gland—obesity	0.000918	0.00918	CbGeAlD
Zoledronate—CA2—adipose tissue—obesity	0.000915	0.00914	CbGeAlD
Zoledronate—CA2—digestive system—obesity	0.000861	0.00861	CbGeAlD
Zoledronate—CA2—adrenal gland—obesity	0.000821	0.0082	CbGeAlD
Zoledronate—ABCC1—liver—obesity	0.000718	0.00717	CbGeAlD
Zoledronate—CA2—endocrine gland—obesity	0.000712	0.00711	CbGeAlD
Zoledronate—CA2—liver—obesity	0.000642	0.00641	CbGeAlD
Zoledronate—Risedronate—PTGS2—obesity	0.000548	0.529	CrCbGaD
Zoledronate—Clodronate—PTGS2—obesity	0.000488	0.471	CrCbGaD
Zoledronate—Myalgia—Orlistat—obesity	0.000283	0.00109	CcSEcCtD
Zoledronate—Loss of consciousness—Sibutramine—obesity	0.000283	0.00108	CcSEcCtD
Zoledronate—Mental disorder—Bupropion—obesity	0.000283	0.00108	CcSEcCtD
Zoledronate—Anxiety—Orlistat—obesity	0.000282	0.00108	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000281	0.00108	CcSEcCtD
Zoledronate—Cough—Sibutramine—obesity	0.000281	0.00108	CcSEcCtD
Zoledronate—Malnutrition—Bupropion—obesity	0.000281	0.00108	CcSEcCtD
Zoledronate—Discomfort—Orlistat—obesity	0.00028	0.00107	CcSEcCtD
Zoledronate—Convulsion—Sibutramine—obesity	0.000279	0.00107	CcSEcCtD
Zoledronate—Blood creatinine increased—Topiramate—obesity	0.000278	0.00107	CcSEcCtD
Zoledronate—Hypertension—Sibutramine—obesity	0.000278	0.00107	CcSEcCtD
Zoledronate—Dry mouth—Orlistat—obesity	0.000277	0.00106	CcSEcCtD
Zoledronate—Dehydration—Topiramate—obesity	0.000276	0.00106	CcSEcCtD
Zoledronate—Dysgeusia—Bupropion—obesity	0.000275	0.00105	CcSEcCtD
Zoledronate—Chest pain—Sibutramine—obesity	0.000274	0.00105	CcSEcCtD
Zoledronate—Arthralgia—Sibutramine—obesity	0.000274	0.00105	CcSEcCtD
Zoledronate—Myalgia—Sibutramine—obesity	0.000274	0.00105	CcSEcCtD
Zoledronate—Anxiety—Sibutramine—obesity	0.000273	0.00105	CcSEcCtD
Zoledronate—Oedema—Orlistat—obesity	0.000272	0.00104	CcSEcCtD
Zoledronate—Anaphylactic shock—Orlistat—obesity	0.000272	0.00104	CcSEcCtD
Zoledronate—Back pain—Bupropion—obesity	0.000272	0.00104	CcSEcCtD
Zoledronate—Abdominal pain upper—Topiramate—obesity	0.000271	0.00104	CcSEcCtD
Zoledronate—Discomfort—Sibutramine—obesity	0.000271	0.00104	CcSEcCtD
Zoledronate—Hypokalaemia—Topiramate—obesity	0.00027	0.00104	CcSEcCtD
Zoledronate—Muscle spasms—Bupropion—obesity	0.00027	0.00103	CcSEcCtD
Zoledronate—Infection—Orlistat—obesity	0.00027	0.00103	CcSEcCtD
Zoledronate—Dry mouth—Sibutramine—obesity	0.000268	0.00103	CcSEcCtD
Zoledronate—Nervous system disorder—Orlistat—obesity	0.000266	0.00102	CcSEcCtD
Zoledronate—Nasopharyngitis—Topiramate—obesity	0.000266	0.00102	CcSEcCtD
Zoledronate—Confusional state—Sibutramine—obesity	0.000265	0.00102	CcSEcCtD
Zoledronate—Vision blurred—Bupropion—obesity	0.000265	0.00101	CcSEcCtD
Zoledronate—Skin disorder—Orlistat—obesity	0.000264	0.00101	CcSEcCtD
Zoledronate—Tremor—Bupropion—obesity	0.000263	0.00101	CcSEcCtD
Zoledronate—Gastritis—Topiramate—obesity	0.000263	0.00101	CcSEcCtD
Zoledronate—Anaphylactic shock—Sibutramine—obesity	0.000263	0.00101	CcSEcCtD
Zoledronate—Oedema—Sibutramine—obesity	0.000263	0.00101	CcSEcCtD
Zoledronate—Hyperhidrosis—Orlistat—obesity	0.000263	0.00101	CcSEcCtD
Zoledronate—Muscular weakness—Topiramate—obesity	0.000262	0.001	CcSEcCtD
Zoledronate—Infection—Sibutramine—obesity	0.000261	0.001	CcSEcCtD
Zoledronate—Ill-defined disorder—Bupropion—obesity	0.000261	0.000998	CcSEcCtD
Zoledronate—Anaemia—Bupropion—obesity	0.00026	0.000994	CcSEcCtD
Zoledronate—Shock—Sibutramine—obesity	0.000259	0.000991	CcSEcCtD
Zoledronate—Abdominal distension—Topiramate—obesity	0.000259	0.00099	CcSEcCtD
Zoledronate—Agitation—Bupropion—obesity	0.000258	0.000989	CcSEcCtD
Zoledronate—Thrombocytopenia—Sibutramine—obesity	0.000257	0.000986	CcSEcCtD
Zoledronate—Asthma—Topiramate—obesity	0.000257	0.000984	CcSEcCtD
Zoledronate—Dysphagia—Topiramate—obesity	0.000257	0.000984	CcSEcCtD
Zoledronate—Angioedema—Bupropion—obesity	0.000257	0.000983	CcSEcCtD
Zoledronate—Tachycardia—Sibutramine—obesity	0.000257	0.000983	CcSEcCtD
Zoledronate—Skin disorder—Sibutramine—obesity	0.000255	0.000978	CcSEcCtD
Zoledronate—Hyperhidrosis—Sibutramine—obesity	0.000254	0.000974	CcSEcCtD
Zoledronate—Malaise—Bupropion—obesity	0.000253	0.00097	CcSEcCtD
Zoledronate—Vertigo—Bupropion—obesity	0.000252	0.000967	CcSEcCtD
Zoledronate—Syncope—Bupropion—obesity	0.000252	0.000965	CcSEcCtD
Zoledronate—Leukopenia—Bupropion—obesity	0.000251	0.000963	CcSEcCtD
Zoledronate—Anorexia—Sibutramine—obesity	0.000251	0.00096	CcSEcCtD
Zoledronate—Sweating increased—Topiramate—obesity	0.00025	0.000958	CcSEcCtD
Zoledronate—Palpitations—Bupropion—obesity	0.000248	0.000951	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Orlistat—obesity	0.000247	0.000948	CcSEcCtD
Zoledronate—Loss of consciousness—Bupropion—obesity	0.000247	0.000946	CcSEcCtD
Zoledronate—Abdominal discomfort—Topiramate—obesity	0.000246	0.000943	CcSEcCtD
Zoledronate—Insomnia—Orlistat—obesity	0.000246	0.000941	CcSEcCtD
Zoledronate—Hypotension—Sibutramine—obesity	0.000246	0.000941	CcSEcCtD
Zoledronate—Cough—Bupropion—obesity	0.000245	0.000939	CcSEcCtD
Zoledronate—Paraesthesia—Orlistat—obesity	0.000244	0.000934	CcSEcCtD
Zoledronate—Pancytopenia—Topiramate—obesity	0.000244	0.000934	CcSEcCtD
Zoledronate—Convulsion—Bupropion—obesity	0.000243	0.000932	CcSEcCtD
Zoledronate—Hypertension—Bupropion—obesity	0.000242	0.000929	CcSEcCtD
Zoledronate—Neutropenia—Topiramate—obesity	0.00024	0.00092	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Sibutramine—obesity	0.00024	0.000918	CcSEcCtD
Zoledronate—Dyspepsia—Orlistat—obesity	0.000239	0.000916	CcSEcCtD
Zoledronate—Arthralgia—Bupropion—obesity	0.000239	0.000916	CcSEcCtD
Zoledronate—Chest pain—Bupropion—obesity	0.000239	0.000916	CcSEcCtD
Zoledronate—Myalgia—Bupropion—obesity	0.000239	0.000916	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Topiramate—obesity	0.000239	0.000914	CcSEcCtD
Zoledronate—Anxiety—Bupropion—obesity	0.000238	0.000913	CcSEcCtD
Zoledronate—Insomnia—Sibutramine—obesity	0.000238	0.000911	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000237	0.00091	CcSEcCtD
Zoledronate—Pollakiuria—Topiramate—obesity	0.000237	0.000909	CcSEcCtD
Zoledronate—Discomfort—Bupropion—obesity	0.000236	0.000905	CcSEcCtD
Zoledronate—Decreased appetite—Orlistat—obesity	0.000236	0.000905	CcSEcCtD
Zoledronate—Paraesthesia—Sibutramine—obesity	0.000236	0.000904	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Orlistat—obesity	0.000235	0.000898	CcSEcCtD
Zoledronate—Dyspnoea—Sibutramine—obesity	0.000234	0.000898	CcSEcCtD
Zoledronate—Fatigue—Orlistat—obesity	0.000234	0.000897	CcSEcCtD
Zoledronate—Dry mouth—Bupropion—obesity	0.000234	0.000896	CcSEcCtD
Zoledronate—Somnolence—Sibutramine—obesity	0.000234	0.000895	CcSEcCtD
Zoledronate—Weight increased—Topiramate—obesity	0.000234	0.000895	CcSEcCtD
Zoledronate—Weight decreased—Topiramate—obesity	0.000232	0.00089	CcSEcCtD
Zoledronate—Pain—Orlistat—obesity	0.000232	0.00089	CcSEcCtD
Zoledronate—Dyspepsia—Sibutramine—obesity	0.000231	0.000887	CcSEcCtD
Zoledronate—Confusional state—Bupropion—obesity	0.000231	0.000885	CcSEcCtD
Zoledronate—Anaphylactic shock—Bupropion—obesity	0.000229	0.000878	CcSEcCtD
Zoledronate—Oedema—Bupropion—obesity	0.000229	0.000878	CcSEcCtD
Zoledronate—Infestation NOS—Topiramate—obesity	0.000229	0.000877	CcSEcCtD
Zoledronate—Infestation—Topiramate—obesity	0.000229	0.000877	CcSEcCtD
Zoledronate—Decreased appetite—Sibutramine—obesity	0.000229	0.000876	CcSEcCtD
Zoledronate—Depression—Topiramate—obesity	0.000228	0.000875	CcSEcCtD
Zoledronate—Infection—Bupropion—obesity	0.000228	0.000872	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Sibutramine—obesity	0.000227	0.00087	CcSEcCtD
Zoledronate—Shock—Bupropion—obesity	0.000225	0.000864	CcSEcCtD
Zoledronate—Renal failure—Topiramate—obesity	0.000225	0.000862	CcSEcCtD
Zoledronate—Pain—Sibutramine—obesity	0.000225	0.000861	CcSEcCtD
Zoledronate—Constipation—Sibutramine—obesity	0.000225	0.000861	CcSEcCtD
Zoledronate—Nervous system disorder—Bupropion—obesity	0.000225	0.000861	CcSEcCtD
Zoledronate—Thrombocytopenia—Bupropion—obesity	0.000224	0.00086	CcSEcCtD
Zoledronate—Feeling abnormal—Orlistat—obesity	0.000224	0.000858	CcSEcCtD
Zoledronate—Tachycardia—Bupropion—obesity	0.000224	0.000857	CcSEcCtD
Zoledronate—Stomatitis—Topiramate—obesity	0.000223	0.000855	CcSEcCtD
Zoledronate—Skin disorder—Bupropion—obesity	0.000223	0.000853	CcSEcCtD
Zoledronate—Conjunctivitis—Topiramate—obesity	0.000223	0.000853	CcSEcCtD
Zoledronate—Urinary tract infection—Topiramate—obesity	0.000223	0.000853	CcSEcCtD
Zoledronate—Gastrointestinal pain—Orlistat—obesity	0.000222	0.000851	CcSEcCtD
Zoledronate—Hyperhidrosis—Bupropion—obesity	0.000222	0.000849	CcSEcCtD
Zoledronate—Anorexia—Bupropion—obesity	0.000218	0.000837	CcSEcCtD
Zoledronate—Haematuria—Topiramate—obesity	0.000218	0.000836	CcSEcCtD
Zoledronate—Feeling abnormal—Sibutramine—obesity	0.000217	0.00083	CcSEcCtD
Zoledronate—Urticaria—Orlistat—obesity	0.000216	0.000827	CcSEcCtD
Zoledronate—Gastrointestinal pain—Sibutramine—obesity	0.000215	0.000824	CcSEcCtD
Zoledronate—Abdominal pain—Orlistat—obesity	0.000215	0.000823	CcSEcCtD
Zoledronate—Body temperature increased—Orlistat—obesity	0.000215	0.000823	CcSEcCtD
Zoledronate—Hypotension—Bupropion—obesity	0.000214	0.00082	CcSEcCtD
Zoledronate—Agranulocytosis—Topiramate—obesity	0.000214	0.000819	CcSEcCtD
Zoledronate—Bradycardia—Topiramate—obesity	0.000209	0.000802	CcSEcCtD
Zoledronate—Urticaria—Sibutramine—obesity	0.000209	0.0008	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Bupropion—obesity	0.000209	0.0008	CcSEcCtD
Zoledronate—Body temperature increased—Sibutramine—obesity	0.000208	0.000796	CcSEcCtD
Zoledronate—Abdominal pain—Sibutramine—obesity	0.000208	0.000796	CcSEcCtD
Zoledronate—Insomnia—Bupropion—obesity	0.000207	0.000794	CcSEcCtD
Zoledronate—Paraesthesia—Bupropion—obesity	0.000206	0.000788	CcSEcCtD
Zoledronate—Hypoaesthesia—Topiramate—obesity	0.000204	0.000783	CcSEcCtD
Zoledronate—Dyspnoea—Bupropion—obesity	0.000204	0.000783	CcSEcCtD
Zoledronate—Somnolence—Bupropion—obesity	0.000204	0.000781	CcSEcCtD
Zoledronate—Urinary tract disorder—Topiramate—obesity	0.000203	0.000778	CcSEcCtD
Zoledronate—Oedema peripheral—Topiramate—obesity	0.000202	0.000776	CcSEcCtD
Zoledronate—Connective tissue disorder—Topiramate—obesity	0.000202	0.000774	CcSEcCtD
Zoledronate—Dyspepsia—Bupropion—obesity	0.000202	0.000773	CcSEcCtD
Zoledronate—Urethral disorder—Topiramate—obesity	0.000201	0.000772	CcSEcCtD
Zoledronate—Hypersensitivity—Orlistat—obesity	0.0002	0.000767	CcSEcCtD
Zoledronate—Decreased appetite—Bupropion—obesity	0.000199	0.000763	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Bupropion—obesity	0.000198	0.000758	CcSEcCtD
Zoledronate—Fatigue—Bupropion—obesity	0.000198	0.000757	CcSEcCtD
Zoledronate—Constipation—Bupropion—obesity	0.000196	0.000751	CcSEcCtD
Zoledronate—Pain—Bupropion—obesity	0.000196	0.000751	CcSEcCtD
Zoledronate—Asthenia—Orlistat—obesity	0.000195	0.000747	CcSEcCtD
Zoledronate—Hypersensitivity—Sibutramine—obesity	0.000194	0.000742	CcSEcCtD
Zoledronate—Pruritus—Orlistat—obesity	0.000192	0.000736	CcSEcCtD
Zoledronate—Eye disorder—Topiramate—obesity	0.000192	0.000736	CcSEcCtD
Zoledronate—Cardiac disorder—Topiramate—obesity	0.000191	0.000731	CcSEcCtD
Zoledronate—Flushing—Topiramate—obesity	0.000191	0.000731	CcSEcCtD
Zoledronate—Feeling abnormal—Bupropion—obesity	0.000189	0.000724	CcSEcCtD
Zoledronate—Asthenia—Sibutramine—obesity	0.000189	0.000723	CcSEcCtD
Zoledronate—Gastrointestinal pain—Bupropion—obesity	0.000187	0.000718	CcSEcCtD
Zoledronate—Angiopathy—Topiramate—obesity	0.000186	0.000714	CcSEcCtD
Zoledronate—Pruritus—Sibutramine—obesity	0.000186	0.000713	CcSEcCtD
Zoledronate—Diarrhoea—Orlistat—obesity	0.000186	0.000712	CcSEcCtD
Zoledronate—Immune system disorder—Topiramate—obesity	0.000186	0.000711	CcSEcCtD
Zoledronate—Mediastinal disorder—Topiramate—obesity	0.000185	0.00071	CcSEcCtD
Zoledronate—Chills—Topiramate—obesity	0.000184	0.000706	CcSEcCtD
Zoledronate—Urticaria—Bupropion—obesity	0.000182	0.000698	CcSEcCtD
Zoledronate—Alopecia—Topiramate—obesity	0.000182	0.000696	CcSEcCtD
Zoledronate—Body temperature increased—Bupropion—obesity	0.000181	0.000694	CcSEcCtD
Zoledronate—Abdominal pain—Bupropion—obesity	0.000181	0.000694	CcSEcCtD
Zoledronate—Mental disorder—Topiramate—obesity	0.00018	0.00069	CcSEcCtD
Zoledronate—Diarrhoea—Sibutramine—obesity	0.00018	0.000689	CcSEcCtD
Zoledronate—Dizziness—Orlistat—obesity	0.00018	0.000688	CcSEcCtD
Zoledronate—Malnutrition—Topiramate—obesity	0.000179	0.000685	CcSEcCtD
Zoledronate—Erythema—Topiramate—obesity	0.000179	0.000685	CcSEcCtD
Zoledronate—Dysgeusia—Topiramate—obesity	0.000175	0.000671	CcSEcCtD
Zoledronate—Dizziness—Sibutramine—obesity	0.000174	0.000666	CcSEcCtD
Zoledronate—Back pain—Topiramate—obesity	0.000173	0.000663	CcSEcCtD
Zoledronate—Vomiting—Orlistat—obesity	0.000173	0.000662	CcSEcCtD
Zoledronate—Muscle spasms—Topiramate—obesity	0.000172	0.000659	CcSEcCtD
Zoledronate—Rash—Orlistat—obesity	0.000171	0.000656	CcSEcCtD
Zoledronate—Dermatitis—Orlistat—obesity	0.000171	0.000656	CcSEcCtD
Zoledronate—Headache—Orlistat—obesity	0.00017	0.000652	CcSEcCtD
Zoledronate—Hypersensitivity—Bupropion—obesity	0.000169	0.000647	CcSEcCtD
Zoledronate—Vision blurred—Topiramate—obesity	0.000169	0.000646	CcSEcCtD
Zoledronate—Tremor—Topiramate—obesity	0.000168	0.000642	CcSEcCtD
Zoledronate—Vomiting—Sibutramine—obesity	0.000167	0.00064	CcSEcCtD
Zoledronate—Ill-defined disorder—Topiramate—obesity	0.000166	0.000636	CcSEcCtD
Zoledronate—Rash—Sibutramine—obesity	0.000166	0.000635	CcSEcCtD
Zoledronate—Dermatitis—Sibutramine—obesity	0.000166	0.000634	CcSEcCtD
Zoledronate—Anaemia—Topiramate—obesity	0.000165	0.000634	CcSEcCtD
Zoledronate—Headache—Sibutramine—obesity	0.000165	0.000631	CcSEcCtD
Zoledronate—Asthenia—Bupropion—obesity	0.000164	0.00063	CcSEcCtD
Zoledronate—Agitation—Topiramate—obesity	0.000164	0.00063	CcSEcCtD
Zoledronate—Pruritus—Bupropion—obesity	0.000162	0.000621	CcSEcCtD
Zoledronate—Nausea—Orlistat—obesity	0.000161	0.000618	CcSEcCtD
Zoledronate—Malaise—Topiramate—obesity	0.000161	0.000618	CcSEcCtD
Zoledronate—Vertigo—Topiramate—obesity	0.000161	0.000616	CcSEcCtD
Zoledronate—Syncope—Topiramate—obesity	0.00016	0.000615	CcSEcCtD
Zoledronate—Leukopenia—Topiramate—obesity	0.00016	0.000614	CcSEcCtD
Zoledronate—Palpitations—Topiramate—obesity	0.000158	0.000606	CcSEcCtD
Zoledronate—Loss of consciousness—Topiramate—obesity	0.000157	0.000602	CcSEcCtD
Zoledronate—Diarrhoea—Bupropion—obesity	0.000157	0.000601	CcSEcCtD
Zoledronate—Nausea—Sibutramine—obesity	0.000156	0.000598	CcSEcCtD
Zoledronate—Cough—Topiramate—obesity	0.000156	0.000598	CcSEcCtD
Zoledronate—Convulsion—Topiramate—obesity	0.000155	0.000594	CcSEcCtD
Zoledronate—Hypertension—Topiramate—obesity	0.000154	0.000592	CcSEcCtD
Zoledronate—Chest pain—Topiramate—obesity	0.000152	0.000584	CcSEcCtD
Zoledronate—Myalgia—Topiramate—obesity	0.000152	0.000584	CcSEcCtD
Zoledronate—Arthralgia—Topiramate—obesity	0.000152	0.000584	CcSEcCtD
Zoledronate—Anxiety—Topiramate—obesity	0.000152	0.000582	CcSEcCtD
Zoledronate—Dizziness—Bupropion—obesity	0.000152	0.000581	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000151	0.00058	CcSEcCtD
Zoledronate—Discomfort—Topiramate—obesity	0.00015	0.000577	CcSEcCtD
Zoledronate—Dry mouth—Topiramate—obesity	0.000149	0.000571	CcSEcCtD
Zoledronate—Confusional state—Topiramate—obesity	0.000147	0.000564	CcSEcCtD
Zoledronate—Oedema—Topiramate—obesity	0.000146	0.000559	CcSEcCtD
Zoledronate—Vomiting—Bupropion—obesity	0.000146	0.000558	CcSEcCtD
Zoledronate—Infection—Topiramate—obesity	0.000145	0.000556	CcSEcCtD
Zoledronate—Rash—Bupropion—obesity	0.000145	0.000554	CcSEcCtD
Zoledronate—Dermatitis—Bupropion—obesity	0.000144	0.000553	CcSEcCtD
Zoledronate—Shock—Topiramate—obesity	0.000144	0.00055	CcSEcCtD
Zoledronate—Headache—Bupropion—obesity	0.000144	0.00055	CcSEcCtD
Zoledronate—Nervous system disorder—Topiramate—obesity	0.000143	0.000549	CcSEcCtD
Zoledronate—Thrombocytopenia—Topiramate—obesity	0.000143	0.000548	CcSEcCtD
Zoledronate—Tachycardia—Topiramate—obesity	0.000143	0.000546	CcSEcCtD
Zoledronate—Skin disorder—Topiramate—obesity	0.000142	0.000543	CcSEcCtD
Zoledronate—Hyperhidrosis—Topiramate—obesity	0.000141	0.000541	CcSEcCtD
Zoledronate—Anorexia—Topiramate—obesity	0.000139	0.000533	CcSEcCtD
Zoledronate—Hypotension—Topiramate—obesity	0.000136	0.000523	CcSEcCtD
Zoledronate—Nausea—Bupropion—obesity	0.000136	0.000522	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Topiramate—obesity	0.000133	0.00051	CcSEcCtD
Zoledronate—Insomnia—Topiramate—obesity	0.000132	0.000506	CcSEcCtD
Zoledronate—Paraesthesia—Topiramate—obesity	0.000131	0.000502	CcSEcCtD
Zoledronate—Dyspnoea—Topiramate—obesity	0.00013	0.000499	CcSEcCtD
Zoledronate—Somnolence—Topiramate—obesity	0.00013	0.000497	CcSEcCtD
Zoledronate—Dyspepsia—Topiramate—obesity	0.000129	0.000492	CcSEcCtD
Zoledronate—Decreased appetite—Topiramate—obesity	0.000127	0.000486	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Topiramate—obesity	0.000126	0.000483	CcSEcCtD
Zoledronate—Fatigue—Topiramate—obesity	0.000126	0.000482	CcSEcCtD
Zoledronate—Pain—Topiramate—obesity	0.000125	0.000478	CcSEcCtD
Zoledronate—Constipation—Topiramate—obesity	0.000125	0.000478	CcSEcCtD
Zoledronate—Feeling abnormal—Topiramate—obesity	0.00012	0.000461	CcSEcCtD
Zoledronate—Gastrointestinal pain—Topiramate—obesity	0.000119	0.000457	CcSEcCtD
Zoledronate—Urticaria—Topiramate—obesity	0.000116	0.000444	CcSEcCtD
Zoledronate—Body temperature increased—Topiramate—obesity	0.000115	0.000442	CcSEcCtD
Zoledronate—Abdominal pain—Topiramate—obesity	0.000115	0.000442	CcSEcCtD
Zoledronate—Hypersensitivity—Topiramate—obesity	0.000108	0.000412	CcSEcCtD
Zoledronate—Asthenia—Topiramate—obesity	0.000105	0.000401	CcSEcCtD
Zoledronate—Pruritus—Topiramate—obesity	0.000103	0.000396	CcSEcCtD
Zoledronate—Diarrhoea—Topiramate—obesity	9.99e-05	0.000383	CcSEcCtD
Zoledronate—Dizziness—Topiramate—obesity	9.66e-05	0.00037	CcSEcCtD
Zoledronate—Vomiting—Topiramate—obesity	9.28e-05	0.000356	CcSEcCtD
Zoledronate—Rash—Topiramate—obesity	9.21e-05	0.000353	CcSEcCtD
Zoledronate—Dermatitis—Topiramate—obesity	9.2e-05	0.000352	CcSEcCtD
Zoledronate—Headache—Topiramate—obesity	9.15e-05	0.00035	CcSEcCtD
Zoledronate—Nausea—Topiramate—obesity	8.67e-05	0.000332	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CYCS—obesity	3.12e-05	0.000132	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARD—obesity	3.1e-05	0.000131	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CD36—obesity	3.1e-05	0.000131	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CAV1—obesity	3.1e-05	0.000131	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOA1—obesity	3.09e-05	0.00013	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ACP5—obesity	3.08e-05	0.00013	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPX1—obesity	3.07e-05	0.000129	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC2A4—obesity	3.06e-05	0.000129	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GCG—obesity	3.06e-05	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC27A1—obesity	3.03e-05	0.000128	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYCS—obesity	3.02e-05	0.000128	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—NCOA1—obesity	3.02e-05	0.000127	CbGpPWpGaD
Zoledronate—ABCC1—Disease—G6PD—obesity	3e-05	0.000127	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CD36—obesity	2.99e-05	0.000126	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GLUL—obesity	2.98e-05	0.000126	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FABP4—obesity	2.98e-05	0.000126	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HK1—obesity	2.97e-05	0.000125	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GOT1—obesity	2.96e-05	0.000125	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GGT1—obesity	2.96e-05	0.000125	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PLG—obesity	2.94e-05	0.000124	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—obesity	2.93e-05	0.000124	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NCOA1—obesity	2.92e-05	0.000123	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP19A1—obesity	2.88e-05	0.000122	CbGpPWpGaD
Zoledronate—CA2—Metabolism—STK11—obesity	2.88e-05	0.000122	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARA—obesity	2.88e-05	0.000122	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	2.87e-05	0.000121	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—obesity	2.83e-05	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD11B1—obesity	2.82e-05	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ECHS1—obesity	2.82e-05	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UCP3—obesity	2.82e-05	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UCP2—obesity	2.82e-05	0.000119	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—obesity	2.82e-05	0.000119	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AGT—obesity	2.79e-05	0.000118	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADH1B—obesity	2.78e-05	0.000117	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARA—obesity	2.78e-05	0.000117	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOB—obesity	2.73e-05	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPAM—obesity	2.73e-05	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACSL1—obesity	2.73e-05	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARGC1B—obesity	2.73e-05	0.000115	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOE—obesity	2.73e-05	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GNB3—obesity	2.73e-05	0.000115	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—obesity	2.72e-05	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—HMOX1—obesity	2.71e-05	0.000115	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAV1—obesity	2.71e-05	0.000114	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOA1—obesity	2.7e-05	0.000114	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—obesity	2.7e-05	0.000114	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AGT—obesity	2.69e-05	0.000113	CbGpPWpGaD
Zoledronate—CA14—Metabolism—POMC—obesity	2.68e-05	0.000113	CbGpPWpGaD
Zoledronate—CA2—Metabolism—COMT—obesity	2.68e-05	0.000113	CbGpPWpGaD
Zoledronate—CA14—Metabolism—INS—obesity	2.67e-05	0.000113	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GNAS—obesity	2.66e-05	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PCK1—obesity	2.65e-05	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HADH—obesity	2.65e-05	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FADS1—obesity	2.65e-05	0.000112	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GNB3—obesity	2.64e-05	0.000111	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARGC1A—obesity	2.64e-05	0.000111	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOE—obesity	2.63e-05	0.000111	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMOX1—obesity	2.63e-05	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LPL—obesity	2.61e-05	0.00011	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAV1—obesity	2.61e-05	0.00011	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOA1—obesity	2.6e-05	0.00011	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOB—obesity	2.6e-05	0.00011	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.59e-05	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACP5—obesity	2.58e-05	0.000109	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GNAS—obesity	2.57e-05	0.000108	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RBP4—obesity	2.55e-05	0.000108	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPX1—obesity	2.55e-05	0.000108	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOB—obesity	2.52e-05	0.000106	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—G6PD—obesity	2.51e-05	0.000106	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HK1—obesity	2.48e-05	0.000105	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SREBF2—obesity	2.48e-05	0.000105	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CD36—obesity	2.48e-05	0.000105	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—obesity	2.48e-05	0.000105	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CG—obesity	2.47e-05	0.000104	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—obesity	2.45e-05	0.000103	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CST3—obesity	2.42e-05	0.000102	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKAR2B—obesity	2.42e-05	0.000102	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LPL—obesity	2.4e-05	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Disease—DCN—obesity	2.4e-05	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPA—obesity	2.4e-05	0.000101	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—obesity	2.38e-05	0.0001	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—obesity	2.38e-05	0.0001	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPIN1—obesity	2.35e-05	9.91e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—POMC—obesity	2.35e-05	9.91e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPX1—obesity	2.34e-05	9.9e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NOS3—obesity	2.34e-05	9.88e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3R1—obesity	2.34e-05	9.88e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NCF2—obesity	2.34e-05	9.86e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—INS—obesity	2.33e-05	9.85e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARA—obesity	2.31e-05	9.74e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA5—obesity	2.3e-05	9.71e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—obesity	2.29e-05	9.69e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NAMPT—obesity	2.29e-05	9.67e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CD36—obesity	2.28e-05	9.64e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GCK—obesity	2.28e-05	9.61e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—POMC—obesity	2.26e-05	9.55e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IAPP—obesity	2.26e-05	9.55e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOC3—obesity	2.26e-05	9.55e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—INS—obesity	2.25e-05	9.5e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AGT—obesity	2.23e-05	9.43e-05	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—obesity	2.2e-05	9.3e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CLOCK—obesity	2.19e-05	9.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC22A1—obesity	2.19e-05	9.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PPARA—obesity	2.19e-05	9.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOE—obesity	2.19e-05	9.24e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SDC1—obesity	2.17e-05	9.17e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—obesity	2.17e-05	9.16e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CD—obesity	2.17e-05	9.15e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOA1—obesity	2.16e-05	9.14e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—obesity	2.16e-05	9.13e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—obesity	2.16e-05	9.12e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—obesity	2.14e-05	9.04e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—obesity	2.14e-05	9.03e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SULT2A1—obesity	2.14e-05	9.03e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GLP1R—obesity	2.14e-05	9.03e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKR1C3—obesity	2.14e-05	9.02e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARA—obesity	2.12e-05	8.96e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—DPYD—obesity	2.1e-05	8.88e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CD—obesity	2.09e-05	8.82e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—obesity	2.06e-05	8.71e-05	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOA1—obesity	2.06e-05	8.69e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AGT—obesity	2.06e-05	8.68e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NOS3—obesity	2.05e-05	8.64e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3R1—obesity	2.05e-05	8.64e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PRKAR2B—obesity	2.02e-05	8.55e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOE—obesity	2.01e-05	8.5e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—DCN—obesity	2.01e-05	8.49e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAV1—obesity	2e-05	8.42e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA1—obesity	1.99e-05	8.4e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GOT2—obesity	1.99e-05	8.38e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.98e-05	8.34e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3R1—obesity	1.97e-05	8.33e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NOS3—obesity	1.97e-05	8.33e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CPT1A—obesity	1.96e-05	8.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FASN—obesity	1.94e-05	8.2e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PARP1—obesity	1.93e-05	8.17e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NAMPT—obesity	1.92e-05	8.1e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—obesity	1.91e-05	8.05e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LIPC—obesity	1.91e-05	8.05e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GCK—obesity	1.91e-05	8.05e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOC3—obesity	1.89e-05	8e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CB—obesity	1.89e-05	7.97e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—POMC—obesity	1.88e-05	7.94e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—obesity	1.87e-05	7.9e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CETP—obesity	1.84e-05	7.76e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CB—obesity	1.82e-05	7.69e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS1—obesity	1.82e-05	7.68e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SDC1—obesity	1.82e-05	7.68e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—obesity	1.82e-05	7.67e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—obesity	1.8e-05	7.62e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TCF7L2—obesity	1.8e-05	7.6e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKR1C3—obesity	1.79e-05	7.55e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A4—obesity	1.77e-05	7.47e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SCARB1—obesity	1.76e-05	7.43e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—obesity	1.75e-05	7.41e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.74e-05	7.33e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—POMC—obesity	1.73e-05	7.3e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—INS—obesity	1.72e-05	7.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—obesity	1.71e-05	7.24e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GOT1—obesity	1.71e-05	7.24e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SREBF1—obesity	1.71e-05	7.22e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRL—obesity	1.69e-05	7.13e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GOT2—obesity	1.66e-05	7.02e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.64e-05	6.92e-05	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—obesity	1.63e-05	6.88e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FASN—obesity	1.63e-05	6.87e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BCHE—obesity	1.62e-05	6.84e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FOXO3—obesity	1.61e-05	6.78e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CD—obesity	1.6e-05	6.75e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—obesity	1.58e-05	6.66e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2E1—obesity	1.56e-05	6.6e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NQO1—obesity	1.55e-05	6.53e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.51e-05	6.39e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3R1—obesity	1.51e-05	6.37e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NOS3—obesity	1.51e-05	6.37e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.5e-05	6.33e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GCG—obesity	1.48e-05	6.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A4—obesity	1.48e-05	6.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYCS—obesity	1.46e-05	6.18e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOB—obesity	1.45e-05	6.14e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GGT1—obesity	1.44e-05	6.06e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GOT1—obesity	1.44e-05	6.06e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA1—obesity	1.41e-05	5.97e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—STK11—obesity	1.39e-05	5.88e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP19A1—obesity	1.39e-05	5.88e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—obesity	1.39e-05	5.88e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LPL—obesity	1.39e-05	5.86e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—obesity	1.38e-05	5.83e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FOXO1—obesity	1.38e-05	5.82e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—obesity	1.32e-05	5.56e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—COMT—obesity	1.3e-05	5.47e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCD—obesity	1.28e-05	5.4e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARGC1A—obesity	1.28e-05	5.39e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNB3—obesity	1.28e-05	5.39e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMOX1—obesity	1.27e-05	5.37e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—obesity	1.25e-05	5.28e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNAS—obesity	1.24e-05	5.25e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOB—obesity	1.22e-05	5.14e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS2—obesity	1.19e-05	5.02e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOE—obesity	1.16e-05	4.91e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPL—obesity	1.16e-05	4.91e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CAV1—obesity	1.15e-05	4.87e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—obesity	1.15e-05	4.86e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOA1—obesity	1.15e-05	4.86e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX1—obesity	1.13e-05	4.79e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—obesity	1.11e-05	4.69e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CD36—obesity	1.1e-05	4.67e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BAD—obesity	1.08e-05	4.58e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—obesity	1.08e-05	4.54e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—obesity	1.05e-05	4.42e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS1—obesity	1.04e-05	4.38e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARA—obesity	1.03e-05	4.34e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AGT—obesity	9.95e-06	4.2e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—INS—obesity	9.94e-06	4.2e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOE—obesity	9.75e-06	4.12e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAV1—obesity	9.66e-06	4.08e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA1—obesity	9.64e-06	4.07e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT2—obesity	9.61e-06	4.06e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—obesity	9.41e-06	3.97e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—obesity	9.23e-06	3.9e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.23e-06	3.9e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—obesity	9.13e-06	3.86e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—obesity	9.07e-06	3.83e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TYK2—obesity	8.88e-06	3.75e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RHOA—obesity	8.81e-06	3.72e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—obesity	8.8e-06	3.71e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3R1—obesity	8.72e-06	3.68e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS3—obesity	8.72e-06	3.68e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—obesity	8.49e-06	3.58e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—obesity	8.49e-06	3.58e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—POMC—obesity	8.37e-06	3.54e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—INS—obesity	8.33e-06	3.52e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTOR—obesity	8.05e-06	3.4e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—obesity	8.05e-06	3.4e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—obesity	7.98e-06	3.37e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—obesity	7.73e-06	3.27e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—obesity	7.63e-06	3.22e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NOS3—obesity	7.3e-06	3.08e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3R1—obesity	7.3e-06	3.08e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—obesity	6.93e-06	2.93e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—obesity	6.74e-06	2.85e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—obesity	6.68e-06	2.82e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—obesity	6.22e-06	2.63e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—obesity	5.78e-06	2.44e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—obesity	5.77e-06	2.43e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—obesity	4.91e-06	2.07e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—obesity	4.34e-06	1.83e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—obesity	4.11e-06	1.73e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—obesity	4.01e-06	1.69e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—obesity	3.36e-06	1.42e-05	CbGpPWpGaD
